{
  "Country": "FR",
  "PICOs": [
    {
      "Population": "Adult patients with advanced non-small cell lung cancer (NSCLC) presenting the KRAS G12C mutation, previously treated",
      "Intervention": "LUMYKRAS (sotorasib)",
      "Comparator": "Docetaxel",
      "Outcomes": "Objective response rate, safety profile, incidence of adverse events"
    },
    {
      "Population": "Patients with advanced solid tumors with KRAS G12C mutation",
      "Intervention": "AMG 510 (sotorasib) monotherapy",
      "Comparator": "Standard treatments (as per ESME cohort)",
      "Outcomes": "Objective response rate evaluated by an independent review committee"
    },
    {
      "Population": "Patients treated with ATUc",
      "Intervention": "LUMYKRAS (sotorasib)",
      "Comparator": "No direct comparator mentioned, observational study",
      "Outcomes": "Efficacy and safety data"
    }
  ]
}